Skip to main content
. 2015 Apr 1;56(3):691–697. doi: 10.3349/ymj.2015.56.3.691

Table 1. Demographic Data of Patients Who Underwent Percutaneous Epidural Neuroplasty According to Their Dural Sac Cross-Sectional Areas.

Group G1-1 G1-2 p value G2-1 G2-2 G2-3 p value
<50% ≥50% G1-1 vs. G1-2 <33.3% 33.3-66.7% >66.7% G2-1 vs. G2-2, G2-1 vs. G2-3, G2-2 vs. G2-3
Age (yrs) 42.8±13.3 48.3±13.3 <0.001 43.5±13.0 44.0±13.7 49.5±13.0 0.795, 0.002, 0.001
Sex (percentage male) 48 49 0.907 43 52 49 0.189, 0.419, 0.562
 Back pain 99 99 0.729 99 100 99 0.152, 0.926, 0.129
 Leg pain 68 68 0.969 72 66 69 0.332, 0.615, 0.582
 Numbness 51 56 0.441 52 50 61 0.778, 0.198, 0.057
 Weakness 1 1 0.729 1 1 1 0.604, 0.678, 0.922
Symptom duration (months) 25.4±34.8 22.8±35.7 0.486 27.6±37.6 22.8±35.4 23.2±34.0 0.356, 0.390, 0.937
 PreVAS (back) 6.9±1.1 6.8±1.3 0.619 6.8±1.0 6.9±1.1 6.8±1.4 0.523, 0.873, 0.395
 PreVAS (leg) 6.9±1.1 4.2±2.1 0.493 3.9±2.3 4.0±2.2 4.3±1.9 0.654, 0.099, 0.153
No. cases 157 206 - 75 154 134 -

VAS, Visual Analog Scale.

Category 1-1, with less than 50%; Category 1-2, with more than 50%; Category 2-1, with less than 33.3%; Category 2-2, between 33.3% and 66.7%; and Category 2-3, with more than 66.7%.